Ibrutinib
Brand name: Imbruvica
Ibrutinib comes in 6 pill versions in our database, in 4 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Ibrutinib pill images
70 mg 1 pill
140 mg 3 pills
- ibr 140 mg Ibrutinib 140 mg White, capsule, 22 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
- ibr 140 Ibrutinib 140 mg Green, round, 9 mm Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
- No picture yet DIN 02434407 Ibrutinib 140 mg Imbruvica, Capsule, sold in Canada Used for waldenstrom macroglobulinemia and b-cell chronic lymphocytic leukemia
280 mg 1 pill
420 mg 1 pill
What is Ibrutinib used for?
Ibrutinib is used for waldenstrom macroglobulinemia, b-cell chronic lymphocytic leukemia and b-cell lymphoma.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
IMBRUVICA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
. 2 Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma with 17p deletion
IMBRUVICA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) with 17p deletion.
. 3 Waldenström’s Macroglobulinemia
IMBRUVICA is indicated for the treatment of adult patients with Waldenström’s macroglobulinemia (WM).
. 4 Chronic Graft versus Host Disease
IMBRUVICA is indicated for the treatment of adult and pediatric patients age 1 year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy.
From the FDA-approved label on DailyMed (published Jan 08, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.